Predicción de la enfermedad coronaria del corazón.

Same author

First Measurement of the Nuclear-Recoil Ionization Yield in Silicon at 100 eV.

Physical review letters·2023

Same author

Publisher's Note: "Neutron emission spectrometer to measure ion temperature on the Fusion Demonstration Plant" [Rev. Sci. Instrum. 93, 113539 (2022)].

The Review of scientific instruments·2022

Same author

Neutron emission spectrometer to measure ion temperature on the Fusion Demonstration Plant.

The Review of scientific instruments·2022

Same author

Multicenter Registry of Patients Receiving Systemic Mold-Active Triazoles for the Management of Invasive Fungal Infections.

Infectious diseases and therapy·2022

Same author

Constraints on Lightly Ionizing Particles from CDMSlite.

Physical review letters·2021

Same author

Light Dark Matter Search with a High-Resolution Athermal Phonon Detector Operated above Ground.

Physical review letters·2021

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Videos de Experimentos Relacionados

Predicción de la enfermedad coronaria del corazón.

Videos de Conceptos Relacionados

First Measurement of the Nuclear-Recoil Ionization Yield in Silicon at 100 eV.

Publisher's Note: "Neutron emission spectrometer to measure ion temperature on the Fusion Demonstration Plant" [Rev. Sci. Instrum. 93, 113539 (2022)].

Neutron emission spectrometer to measure ion temperature on the Fusion Demonstration Plant.

Multicenter Registry of Patients Receiving Systemic Mold-Active Triazoles for the Management of Invasive Fungal Infections.

Constraints on Lightly Ionizing Particles from CDMSlite.

Light Dark Matter Search with a High-Resolution Athermal Phonon Detector Operated above Ground.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Videos de Experimentos Relacionados

Predicción de la enfermedad coronaria del corazón.

Videos de Conceptos Relacionados

Artículos Relacionados

First Measurement of the Nuclear-Recoil Ionization Yield in Silicon at 100 eV.

Publisher's Note: "Neutron emission spectrometer to measure ion temperature on the Fusion Demonstration Plant" [Rev. Sci. Instrum. 93, 113539 (2022)].

Neutron emission spectrometer to measure ion temperature on the Fusion Demonstration Plant.

Multicenter Registry of Patients Receiving Systemic Mold-Active Triazoles for the Management of Invasive Fungal Infections.

Constraints on Lightly Ionizing Particles from CDMSlite.

Light Dark Matter Search with a High-Resolution Athermal Phonon Detector Operated above Ground.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.